alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 738 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 738

         For the relief of Mykhaylo Gnatyuk and Melnik Gnatyuk.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 1, 2023

Mr. Davis of Illinois introduced the following bill; which was referred 
                   to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
         For the relief of Mykhaylo Gnatyuk and Melnik Gnatyuk.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PERMANENT RESIDENT STATUS FOR MYKHAYLO GNATYUK AND MELNIK 
              GNATYUK.

    (a) In General.--Notwithstanding subsections (a) and (b) of section 
201 of the Immigration and Nationality Act, Mykhaylo Gnatyuk and Melnik 
Gnatyuk shall each be eligible for issuance of an immigrant visa or for 
adjustment of status to that of an alien lawfully admitted for 
permanent residence upon filing an application for issuance of an 
immigrant visa under section 204 of such Act or for adjustment of 
status to lawful permanent resident.
    (b) Adjustment of Status.--If Mykhaylo Gnatyuk or Melnik Gnatyuk 
enters the United States before the filing deadline specified in 
subsection (c), he or she shall be considered to have entered and 
remained lawfully and shall, if otherwise eligible, be eligible for 
adjustment of status under section 245 of the Immigration and 
Nationality Act as of the date of the enactment of this Act.
    (c) Deadline for Application and Payment of Fees.--Subsections (a) 
and (b) shall apply only if the application for issuance of an 
immigrant visa or the application for adjustment of status is filed 
with appropriate fees within 2 years after the date of the enactment of 
this Act.
    (d) Reduction of Immigrant Visa Number.--Upon the granting of an 
immigrant visa or permanent residence to Mykhaylo Gnatyuk and Melnik 
Gnatyuk, the Secretary of State shall instruct the proper officer to 
reduce by 2, during the current or next following fiscal year, the 
total number of immigrant visas that are made available to natives of 
the country of the aliens' birth under section 203(a) of the 
Immigration and Nationality Act or, if applicable, the total number of 
immigrant visas that are made available to natives of the country of 
the aliens' birth under section 202(e) of such Act.
    (e) Denial of Preferential Immigration Treatment for Certain 
Relatives.--The natural parents, brothers, and sisters of Mykhaylo 
Gnatyuk and Melnik Gnatyuk shall not, by virtue of such relationship, 
be accorded any right, privilege, or status under the Immigration and 
Nationality Act.
                                 <all>
```
§ 211.82 Receipt and storage of untested components, drug product containers, and closures. ( a ) Upon receipt and before acceptance, each container or grouping of containers of components, drug product containers, and closures shall be examined visually for appropriate labeling as to contents, container damage or broken seals, and contamination.
( b ) Components, drug product containers, and closures shall be stored under quarantine until they have been tested or examined, whichever is appropriate, and released. Storage within the area shall conform to the requirements of § 211.80.
[43 FR 45077, Sept. 29, 1978, as amended at 73 FR 51932, Sept. 8, 2008]
#### § 171.102 Effective date of regulation.

A regulation published in accordance with § 171.100(a) shall become effective upon publication in the Federal Register.
**EXHIBIT 32.1****CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350**Pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,I, Gordon Ellis, President and Chief Executive Officer, certify that:1.   To my knowledge, this report fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and2.   To my knowledge, the information in this report fairly presents, in all material respects, thefinancial condition and results of operations of International Absorbents Inc. as of April 30,2006.        Date:  June 9, 2006   /s/   GORDON ELLIS    Gordon Ellis    *President and Chief Executive Officer*
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-START>                             JUL-01-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                      15,212,211
<SECURITIES>                                  (64,504)
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            15,147,707
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              15,147,707
<CURRENT-LIABILITIES>                          250,375
<BONDS>                                              0
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                  14,897,332
<TOTAL-LIABILITY-AND-EQUITY>                15,147,707
<SALES>                                              0
<TOTAL-REVENUES>                             (435,647)
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                10,372
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (446,019)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (446,019)
<EPS-PRIMARY>                                 (102.06)
<EPS-DILUTED>                                        0
        

</TABLE>
[No. 21357-5-II.

Division Two.

January 9, 1998.]

#### The State of Washington, *Respondent,*v. Larry R. Jackman, *Appellant.*

Appeal from a judgment of the Superior Court for Pierce County, No. 95-1-03976-8, Thomas R. Sauriol, J., entered November 7, 1996. *Affirmed*by unpublished opinion per Hunt, J., concurred in by Morgan and Armstrong, JJ.
###### Editorial Note on Part 9

#### Editorial Note:

Nomenclature changes to part 9 appear at 82 FR 52825, Nov. 15, 2017.

#### § 9.204 Procedure in the event of an adverse ruling.

If the court or other judicial or quasi-judicial authority declines to stay the effect of the demand in response to a request made in accordance with § 9.203 pending receipt of instructions, or if the court or other authority rules that the demand must be complied with irrespective of instructions not to produce the material or disclose the information sought, the employee upon whom the demand has been made shall respectfully decline to comply with the demand, citing these regulations and *United States ex rel. Touhy* v. *Ragen,* 340 U.S. 462 (1951).
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF HANCOCK FABRICS INC. FOR THE PERIOD ENDED JULY 30, 2000
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JAN-28-2001
<PERIOD-START>                             JAN-31-2000
<PERIOD-END>                               JUL-30-2000
<CASH>                                           4,192
<SECURITIES>                                         0
<RECEIVABLES>                                      875
<ALLOWANCES>                                         0
<INVENTORY>                                    131,262
<CURRENT-ASSETS>                               138,308
<PP&E>                                          26,740
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 183,253
<CURRENT-LIABILITIES>                           53,504
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           291
<OTHER-SE>                                      74,139
<TOTAL-LIABILITY-AND-EQUITY>                    74,430
<SALES>                                        184,169
<TOTAL-REVENUES>                               184,169
<CGS>                                           92,718
<TOTAL-COSTS>                                   92,718
<OTHER-EXPENSES>                                85,739
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,380
<INCOME-PRETAX>                                  4,332
<INCOME-TAX>                                     1,567
<INCOME-CONTINUING>                              2,765
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,765
<EPS-BASIC>                                        .16
<EPS-DILUTED>                                      .16


</TABLE>
#### § 182.50 Certain other spices, seasonings, essential oils, oleoresins, and natural extracts.

Certain other spices, seasonings, essential oils, oleoresins, and natural extracts that are generally recognized as safe for their intended use, within the meaning of section 409 of the Act, are as follows:

| Common name | Derivation |
| --- | --- |
| Ambergris | Physeter macrocephalus L. |
| Castoreum | Castor fiber L. and C. canadensis Kuhl. |
| Civet (zibeth, zibet, zibetum) | Civet cats, Viverra civetta Schreber and Viverra zibetha Schreber. |
| Cognac oil, white and green | Ethyl oenanthate, so-called. |
| Musk (Tonquin musk) | Musk deer, Moschus moschiferus L. |
Exhibit
      32.2 Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant
      to
      Section 906 of the Sarbanes-Oxley Act of 2002.




In
      connection with the Quarterly Report of Calgon Carbon Corporation (the
“Company”) on Form 10-Q for the period ended June 30, 2007 as filed with the
      Securities and Exchange Commission on the date hereof (the “Report”), I, Leroy
      M. Ball, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
      § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,
      that **** to
      the
      best of my knowledge:





(1)
      The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company for the periods
      presented therein.




/s/
                Leroy M. BallChief
                Financial Officer
              August
                9, 2007




This
      certification accompanies this Report pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by
      the
      Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
      Section 18 of the Securities Exchange Act of 1934, as amended.
<PAGE>   1
                                                                   EXHIBIT 23.02


               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" and the use
of our report dated January 28, 1998 (except for Note 9, as to which the date
is February 28, 1998), included in the Proxy Statement of GenQuest, Inc. that
is made a part of the Registration Statement on Form S-4 and Prospectus of
Corixa Corporation for the registration of additional shares of its Common
Stock.

/s/ ERNST & YOUNG LLP

Seattle, Washington
June 25, 1998
<PAGE>

EXHIBIT 32 (B)

     CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Northland Cable Properties Seven
Limited Partnership (the "Partnership") on Form 10Q for the period ended March
31, 2004 as filed with the Securities and Exchange Commission on the date hereof
(the "Form 10-Q"), I, Gary Jones, President of Northland Communications
Corporation, the General Partner, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that;

      (1)   The Form 10-Q fully complies with the requirements of Section 13 (a)
            or (15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or
            78(d)); and

      (2)   The information contained in the Form 10-Q fairly presents in all
            material respects, the financial condition and results of operations
            of the Partnership.

DATE: 5-17-04

/s/  GARY S. JONES
     --------------------------------
     Gary S. Jones
     President

A signed original of this written statement required by Section 906 has been
provided to Northland Cable Properties Seven Limited Partnership and will be
retained by Northland Cable Properties Seven Limited Partnership and furnished
to the Securities and Exchange Commission or its staff upon request.
§ 3.4 Designated agency component. ( a ) To designate the agency component with primary jurisdiction for the premarket review and regulation of a combination product, the agency shall determine the primary mode of action of the product. Where the primary mode of action is that of: ( 1 ) A drug (other than a biological product), the agency component charged with premarket review of drugs shall have primary jurisdiction;
( 2 ) A device, the agency component charged with premarket review of devices shall have primary jurisdiction;
( 3 ) A biological product, the agency component charged with premarket review of biological products shall have primary jurisdiction.
( b ) In some situations, it is not possible to determine, with reasonable certainty, which one mode of action will provide a greater contribution than any other mode of action to the overall therapeutic effects of the combination product. In such a case, the agency will assign the combination product to the agency component that regulates other combination products that present similar questions of safety and effectiveness with regard to the combination product as a whole. When there are no other combination products that present similar questions of safety and effectiveness with regard to the combination product as a whole, the agency will assign the combination product to the agency component with the most expertise related to the most significant safety and effectiveness questions presented by the combination product.
( c ) The designation of one agency component as having primary jurisdiction for the premarket review and regulation of a combination product does not preclude consultations by that component with other agency components or, in appropriate cases, the requirement by FDA of separate applications.
[56 FR 58756, Nov. 21, 1991, as amended at 70 FR 49861, Aug. 25, 2005]
<PAGE>   1
                                                                   EXHIBIT 10.27
                                                                   -------------


           SUPPLEMENTAL SCHEDULE OF DIRECTORS AND EXECUTIVE OFFICERS
                             WHO ARE PARTIES TO AN
                           INDEMNIFICATION AGREEMENT

SIGNATORY                          CAPACITY
---------                          --------

Roger D. Blackwell                 Director

Cynthia D. Fields                  Director and Officer

E. Gordon Gee                      Director

Kenneth B. Gilman                  Director and Officer

Philip E. Mallott                  Officer

Grace A. Nichols                   Director and Officer

Beth M. Pritchard                  Director and Officer

Donald B. Shackelford              Director

Leslie H. Wexner                   Director and Officer

Alex Shumate                       Director

William E. Kirwan                  Director
**Exhibit 32.1**Certification Pursuant to 18 U.S.C. Section 1350.In connection with the Quarterly Report of Front Range Capital Corporation (the “Company”) on Form10-Q for the period ending June 30, 2005 as filed with the Securities and Exchange Commission onthe date hereof (the “Report”), I, William A. Mitchell, Jr. Chief Executive Officer of the Company,certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that: (1) The Report fully complies with the requirements of section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and  (2) The information contained in the Report fairly presents, in all materialrespects, the financial condition and results of operations of the Company.     /s/ William A. Mitchell, Jr.     William A. Mitchell, Jr.  Chief Executive OfficerA signed original of this written statement required by Section 906 has been provided to FrontRange Capital Corporation and will be retained by Front Range Capital Corporation and furnished tothe Securities and Exchange Commission or its staff upon request.
§ 163.117 Cocoa with dioctyl sodium sulfosuccinate for manufacturing. ( a ) *Description.* Cocoa with dioctyl sodium sulfosuccinate for manufacturing is the food additive complying with the provisions prescribed in § 172.520 of this chapter. It conforms to the definition and standard of identity, and is subject to the requirements for label declaration of ingredients, for breakfast cocoa in § 163.112, or for cocoa in § 163.113, or for lowfat cocoa in § 163.114, except that the food additive contains dioctyl sodium sulfosuccinate (complying with the requirements of § 172.810 of this chapter, including the limit of not more than 0.4 percent by weight of the finished food additive).
( b ) *Nomenclature.* The name of the food additive is “cocoa with dioctyl sodium sulfosuccinate for manufacturing” to which is added any modifier of the word “cocoa” required by the definition and standard of identity to which the food additive otherwise conforms. When the food additive is used in a fabricated food, the phrase “for manufacturing” may be omitted from any declaration of ingredients required under § 101.4 of this chapter.
EXHIBIT 32.1



CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, I, Gordon L. Ellis, President and Chief Executive Officer of International Absorbents Inc., certify that:

1.

To my knowledge, this report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



2.

To my knowledge, the information in this report fairly presents, in all material respects, the financial condition and results of operations of International Absorbents Inc. as of October 31, 2008.



|                            |     |                                       
|--------------------------- | --- | --------------------------------------
|Date:     December 15, 2008 | By: | /s/ GORDON L. ELLIS                   
|                            |     | Gordon L. Ellis                       
|                            |     | President and Chief Executive Officer)
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7377 Received in Senate (RDS)]

<DOC>
118th CONGRESS
  2d Session
                                H. R. 7377

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 23, 2024

                                Received

_______________________________________________________________________

                                 AN ACT

 
  To amend the Federal Oil and Gas Royalty Management Act of 1982 to 
 improve the management of royalties from oil and gas leases, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Royalty Resiliency Act''.

SEC. 2. DETERMINATION OF ALLOCATIONS OF PRODUCTION FOR UNITS AND 
              COMMUNITIZATION AGREEMENTS.

    Section 111(j) of the Federal Oil and Gas Royalty Management Act of 
1982 (30 U.S.C. 1721(j)), as amended by the Federal Oil and Gas Royalty 
Simplification and Fairness Act of 1996 (Public Law 104-185), is 
amended to read as follows:
    ``(j) The Secretary shall issue all determinations of allocations 
of production for units and communitization agreements within 120 days 
of a request for determination. Until the Secretary issues the 
determination, the lessee or its designee of a lease in a unit or 
communitization agreement shall report and pay royalties on oil and gas 
production for each production month in accordance with the terms of 
the proposed allocation of production for the unit or communitization 
agreement. After the Secretary issues the determination, the lessee or 
its designee shall, as necessary, correct such reports and the amount 
of royalties paid on oil and gas production under the unit or 
communitization agreement by not later than the end of the third month 
following the month in which the lessee or its designee receives the 
determination from the Secretary. Subject to the full and timely 
monthly payment of royalties to all parties in accordance with the 
terms of the proposed allocation of production for the unit or 
communitization agreement, the Secretary shall waive interest due on 
obligations subject to the determination until the end of the third 
month following the month in which the lessee or its designee receives 
the determination from the Secretary. This subsection shall not apply 
to unit or communization agreements containing Indian lands.''.

            Passed the House of Representatives July 22, 2024.

            Attest:

                                             KEVIN F. MCCUMBER,

                                                                 Clerk.
```
DISTRICT COURT OF APPEAL OF FLORIDA

SECOND DISTRICT

In the Interest of A.C., S.M., K.C., B.L., and M.L., children.

S.L.,

Appellant,

v.

DEPARTMENT OF CHILDREN AND FAMILIES and

STATEWIDE GUARDIAN AD LITEM,

Appellees.

Nos. 2D2023-2393

July 17, 2024

Appeal from the Circuit Court for Hillsborough County; Lisa D. 

Campbell, Judge.

David J. Joffe of Joffe Law, P.A., Ft. Lauderdale, for Appellant.

Mary Soorus, Appellate Counsel, Children's Legal Services, Tampa, for 

Appellee Department of Children and Families.

Sara Elizabeth Goldfarb, Statewide Director of Appeals and Laura J. Lee, 

Assistant Director of Appeals, Statewide Guardian ad Litem, Tallahassee, 

Attorneys for the Statewide Guardian ad Litem o/b/o A.C., S.M., K.C., 

B.L., and M.L.

PER CURIAM.
2

Affirmed.

SLEET, C.J., and VILLANTI and ATKINSON, JJ., Concur.

Opinion subject to revision prior to official publication.